Latest Breaking News On - Highlight company - Page 1 : comparemela.com

Shareholder Warns Maker of Oreo That They are Endangering Their Brand

Shareholder Warns Maker of Oreo That They are Endangering Their Brand
pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.

United statesDan renePaul chesserPeter flahertyAnheuser busch inbevHuman rights campaignWorld economic forumExchange commissionCenter dan reneMondelez internationalNews networkCompany websiteMatter global network foundationWorld health organizationNational legalWarns maker

Genprex to Present at Upcoming September Investor Conference

/PRNewswire/ Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies.

United statesDrug administrationExchange commissionCompany websiteGenprex incHighlight companyGene therapiesChief financial officerRyan conferAnnual global investmentChief financialInvestor relationsNanoparticle delivery systemFast track designationLanguage concerning forward looking statementsPrivate securities litigation reform act

Genprex to Present at Upcoming December Investor Conference

Genprex to Present at Upcoming December Investor Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesContactkalyn dabbsCatherine vaczyReed smithExchange commissionGenprex incDrug administrationPrnewswire genprex incCorporate presentationHighlight companyGene therapiesExecutive vice presidentGeneral counselChief strategy officerGrowth conferenceconference datesNew york citypresenter

Genprex to Present at Upcoming October Investor and Industry Conferences

/PRNewswire/ Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies.

United statesLos angelesCatherine vaczyKalyn dabbsLeipziger messeMark bergerExchange commissionSeapot hotelGenprex incDrug administrationPrnewswire genprex incClinical presentationsHighlight companyGene therapiesWyndham grand jupiter at harbourside placeExecutive vice president

Genprex to Present at Upcoming September Investor Conference

/PRNewswire/ Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies.

United statesExchange commissionGenprex incDrug administrationCorporate presentationHighlight companyGene therapiesChief financial officerRyan conferAnnual global investmentChief financialNanoparticle delivery systemFast track designationPrivate securities litigation reform actAnnual report